<DOC>
	<DOCNO>NCT01706029</DOCNO>
	<brief_summary>Rheumatoid Arthritis ( RA ) inflammatory chronic rheumatism pain remain priority domain improvement patient instead good control inflammatory disease treatment , even biotherapeutics . Some study show less 50 % patient satisfied care pain , whereas criterion evaluation RA improve treatment . The chronic pain , complex multifactorial subjective phenomenon require multidimensional evaluation , current criterion follow-up RA ( DAS28 , ACR criterion ) investigate pain single dimension pain intensity . So , investigator arrange explanation observe dichotomy improvement clinical biological inflammatory criterion RA hand persistence pain . On hand , interleukin ( IL ) -6 , IL-17 IL-33 cytokine occur physiopathology RA probably pain process accord recent data literature . The aim study : - ass multidimensional origin pain RA patient mean questionnaire - look possible correlation serum level cytokine pain .</brief_summary>
	<brief_title>Pain Evaluation Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>Adults RA treat DMARDs and/or biotherapy , Capable provide write consent Patients affect painful disease one RA , Fibromyalgia , A malignancy disease , An hemopathy , Psychiatric disorder dementia Acute infectious disease Receive receive antiIL6 therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>